Comparative stroke risk of antiepileptic drugs in patients with epilepsy

Epilepsia

Volumn 54, Issue 1, 2013, Pages 172-180

  Hsieh, Cheng Yang ^a,b   Lai, Edward Chia Cheng ^a   Yang, Yea Huei Kao ^a,c   Lin, Swu Jane ^d  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TAINAN SIN LAU HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antiepileptic drugs; Patients with epilepsy; Pharmacoepidemiology; Stroke risk

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; ASIAN; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; COMPARATIVE STUDY; DOSE RESPONSE; EMERGENCY CARE; EPILEPSY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOTHERAPY; POPULATION RESEARCH; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; VALPROIC ACID; YOUNG ADULT;

EID: 84872089385     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03693.x     Document Type: Article

References (40)

1. Belcastro V, Striano P, Gorgone G, Costa C, Ciampa C, Caccamo D, Pisani LR, Oteri G, Marciani MG, Aguglia U, Striano S, Ientile R, Calabresi P, Pisani F,. (2010) Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia 51: 274-279.
2. Bowes AJ, Khan MI, Shi Y, Robertson L, Werstuck GH,. (2009) Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis. Am J Pathol 174: 330-342.
3. Bramswig S, Sudhop T, Luers C, von Bergmann K, Berthold HK,. (2003) Lipoprotein(a) concentration increases during treatment with carbamazepine. Epilepsia 44: 457-460.
4. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML,. (2011) Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20: 236-242.
5. Chengappa KN, Chalasani L, Brar JS, Parepally H, Houck P, Levine J,. (2002) Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review. Clin Ther 24: 1576-1584.
6. Chuang YC, Chuang HY, Lin TK, Chang CC, Lu CH, Chang WN, Chen SD, Tan TY, Huang CR, Chan SH,. (2012) Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia 53: 120-128.
7. Cockerell OC, Johnson AL, Sander JW, Hart YM, Goodridge DM, Shorvon SD,. (1994) Mortality from epilepsy: results from a prospective population-based study. Lancet 344: 918-921.
8. Ding D, Wang W, Wu J, Ma G, Dai X, Yang B, Wang T, Yuan C, Hong Z, de Boer HM, Prilipko L, Sander JW,. (2006) Premature mortality in people with epilepsy in rural China: a prospective study. Lancet Neurol 5: 823-827.
9. Duncan JS, Sander JW, Sisodiya SM, Walker MC,. (2006) Adult epilepsy. Lancet 367: 1087-1100.
10. Gaitatzis A, Carroll K, Majeed A, J WS,. (2004) The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45: 1613-1622.
11. Hamed SA, Hamed EA, Hamdy R, Nabeshima T,. (2007) Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res 74: 183-192.
12. Hsieh LP, Huang CY,. (2011) Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study. Epilepsy Res 96: 81-88.
13. Hsieh FI, Lien LM, Chen ST, Bai CH, Sun MC, Tseng HP, Chen YW, Chen CH, Jeng JS, Tsai SY, Lin HJ, Liu CH, Lo YK, Chen HJ, Chiu HC, Lai ML, Lin RT, Sun MH, Yip BS, Chiou HY, Hsu CY,. (2010) Get with the guidelines-stroke performance indicators: surveillance of stroke care in the taiwan stroke registry: get with the guidelines-stroke in Taiwan. Circulation 122: 1116-1123.
14. Hu CC, Ho JD, Lin HC,. (2010) Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study. Stroke 41: 613-617.
15. Jaja C, Burke W, Thummel K, Edwards K, Veenstra DL,. (2008) Cytochrome p450 enzyme polymorphism frequency in indigenous and native American populations: a systematic review. Community Genet 11: 141-149.
16. Kang JH, Ho JD, Chen YH, Lin HC,. (2009) Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke 40: 3443-3448.
17. Kang JH, Sheu JJ, Lin HC,. (2010) Increased risk of stroke after adhesive capsulitis: a population-based study. Stroke 41: 1044-1047.
18. Kang JH, Chung SD, Xirasagar S, Jaw FS, Lin HC,. (2011) Increased risk of stroke in the year after a hip fracture: a population-based follow-up study. Stroke 42: 336-341.
19. Khan MI, Pichna BA, Shi Y, Bowes AJ, Werstuck GH,. (2009) Evidence supporting a role for endoplasmic reticulum stress in the development of atherosclerosis in a hyperglycaemic mouse model. Antioxid Redox Signal 11: 2289-2298.
20. Lee TM, Lin MS, Chang NC,. (2007) Inhibition of histone deacetylase on ventricular remodeling in infarcted rats. Am J Physiol Heart Circ Physiol 293: H968-H977.
21. Lin HC, Chao PZ, Lee HC,. (2008) Sudden sensorineural hearing loss increases the risk of stroke: a 5-year follow-up study. Stroke 39: 2744-2748.
22. Linnebank M, Moskau S, Semmler A, Widman G, Stoffel-Wagner B, Weller M, Elger CE,. (2011) Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol 69: 352-359.
23. Martin CK, Han H, Anton SD, Greenway FL, Smith SR,. (2009) Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial. J Psychopharmacol 23: 814-825.
24. Mehta S, Johnson ML, Chen H, Aparasu RR,. (2010) Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. J Clin Psychiatry 71: 689-698.
25. Mintzer S,. (2010) Metabolic consequences of antiepileptic drugs. Curr Opin Neurol 23: 164-169.
26. Mintzer S, Mattson RT,. (2009) Should enzyme-inducing antiepileptic drugs be considered first-line agents? Epilepsia 50 (Suppl. 8): 42-50.
27. Mintzer S, Skidmore CT, Abidin CJ, Morales MC, Chervoneva I, Capuzzi DM, Sperling MR,. (2009) Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol 65: 448-456.
28. Nikolaos T, Stylianos G, Chryssoula N, Irini P, Christos M, Dimitrios T, Konstantinos P, Antonis T,. (2004) The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med Sci Monit 10: MT50-MT52.
29. Nilsson L, Tomson T, Farahmand BY, Diwan V, Persson PG,. (1997) Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy. Epilepsia 38: 1062-1068.
30. Ohira T, Shahar E, Iso H, Chambless LE, Rosamond WD, Sharrett AR, Folsom AR,. (2011) Carotid artery wall thickness and risk of stroke subtypes: the atherosclerosis risk in communities study. Stroke 42: 397-403.
31. Olesen JB, Abildstrom SZ, Erdal J, Gislason GH, Weeke P, Andersson C, Torp-Pedersen C, Hansen PR,. (2011a) Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study. Pharmacoepidemiol Drug Saf 20: 964-971.
32. Olesen JB, Hansen PR, Abildstrom SZ, Andersson C, Weeke P, Schmiegelow M, Erdal J, Torp-Pedersen C, Gislason GH,. (2011b) Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study. Pharmacoepidemiol Drug Saf 20: 146-153.
33. Perucca E, Tomson T,. (2011) The pharmacological treatment of epilepsy in adults. Lancet Neurol 10: 446-456.
34. Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, Licata G,. (2004) Cerebrovascular risk factors and clinical classification of strokes. Semin Vasc Med 4: 287-303.
35. Sheu JJ, Chiou HY, Kang JH, Chen YH, Lin HC,. (2010a) Tuberculosis and the risk of ischemic stroke: a 3-year follow-up study. Stroke 41: 244-249.
36. Sheu JJ, Kang JH, Lou HY, Lin HC,. (2010b) Reflux esophagitis and the risk of stroke in young adults: a 1-year population-based follow-up study. Stroke 41: 2033-2037.
37. Tan TY, Lu CH, Chuang HY, Lin TK, Liou CW, Chang WN, Chuang YC,. (2009) Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis. Epilepsia 50: 1579-1586.
38. Tomoum HY, Awadallah, Fouad DA, Ali AH,. (2008) Lipid profile, apolipoproteins A and B in children with epilepsy. J Child Neurol 23: 1275-1281.
39. Yang YW, Chen YH, Xirasagar S, Lin HC,. (2011) Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study. Stroke 42: 319-323.
40. Zaidi A, Clough P, Cooper P, Scheepers B, Fitzpatrick AP,. (2000) Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol 36: 181-184.